Jason M Link
4PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial.Zev A Wainberg, Jason M Link, Alykhan Premji
|Sep 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer.Chloe L Bowman, Colin J Daniel, Eric J Carlson
|Jan 09, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer.Jason M Link, Jennifer R Eng, Carl Pelz
|May 17, 2023
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling.Razmik Ghukasyan, Keke Liang, Kevin Chau
Pageof 1
Frequent Collaborators
2 joint publications
Ellen M Langer
2 joint publications
Andrew C Adey
2 joint publications
Koei Chin
2 joint publications
Jennifer R Eng
2 joint publications
Rosalie C Sears
2 joint publications
Isabel A English
2 joint publications
Timothy R Donahue
2 joint publications
Caius G Radu
1 joint publications
Keke Liang
1 joint publications
Charlotte Chan
